Ra Capital Management, L.P. - Director, 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ra Capital Management, L.P. - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Ra Capital Management, L.P. for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9.96M $97.5M $9.79 Mar 27, 2024 Indirect
Stock Option (Right to Buy) 40K Jun 20, 2024 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.